Pfizer's human trial involved 45 participants aged 18 to 55 receiving either 10, 30, or 100 microgram doses of the BNT162b1 vaccine or a placebo over a 21 day period. The compound successfully created antibodies for combatting the coronavirus in all participants receiving two of the 10 or 30 microgram doses, according to a Wednesday release.
Pfizer said patients created between 1.8 and 2.8 times the antibodies seen in those who have recovered from COVID-19. Jeffrey Halley, senior market analyst, Asia-Pacific at OANDA, said:"Based on a vaccine trial containing 45 people, including placebos, the v-shaped recovery gnomes, are once again, reaching for the sky."
Naeem Aslam, chief market analyst at Avatrade, said:"The positive news on coronavirus vaccine trial data that came out yesterday still has a positive influence on the sentiment. But the reality is that we are still long way away from home as these results are still very much associated with earlier trial data.Here's the market roundup as of 10.20 a.m in London :
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer stock jumps after it reports positive data in early-stage coronavirus vaccine trialStop releasing these stupid stories about the cure to Corona! Just because they have a drug doesn’t mean squat. Human trials are needed and they must work!! Then there is the pesky problem of being able to get what you need for mass production. Geez. Only 24 people and they release the results? Come on people SquawkStreet i wan't be taking that poison.
Source: CNBC - 🏆 12. / 72 Read more »
Covid-19 vaccine from Pfizer and BioNTech shows positive resultsAn experimental Covid-19 vaccine being developed by the drug giant Pfizer and the biotech firm BioNTech spurred immune responses in healthy patients, but also caused fever and other side effects, especially at higher doses, STAT News reports. How do we feel about this? Too rushed? Too much money in a “cure” for it to be safe? I’m torn. Thoughts? i dont buy it. Samir_Madani How can you do this with a straight face megtirrell How many fake vaccine pumps is gonna facilitate jimcramer SaraEisen davidfaber? Are you guys happy to be the Pump and Dump channel?
Source: CNBC - 🏆 12. / 72 Read more »
Chobani, Pfizer and SAP join running list of companies pulling Facebook adsAdvertisers are continuing to join the 'StopHateforProfit' campaign by vowing to stop spending money on Facebook ads in July to pressure the company to better prevent the spread of hate speech and misinformation. Good If more companies continue to join the Facebook boycott, the stock will reach all time highs! Bullish news Boycott any company that virtue signals. Don't fall for this, they are all still using Facebook pixel. They'll go back. This is just to score some woke points.
Source: CNBC - 🏆 12. / 72 Read more »
COVID-19 vaccine: Pfizer vaccine shows potential in early human trialsA Pfizer COVID-19 vaccine has shown potential and was found to be well tolerated in early-stage human trials, company says. The drug is one of 17 being tested on humans, and is the 4th early-stage COVID-19 drug to show promise in human testing. Crossing all my crossables that this works! Then they're going to charge you a million dollars in the united states. That's with insurance. This is market manipulation. They did not have a published peer reviewed study, just posted on their website. Oh, and they tested 36 people only, 75% of them developed highfever, 85% developed muscle pain and headaches.
Source: NBCNews - 🏆 10. / 86 Read more »
Dow Jumps 100 Points After Pfizer Coronavirus Vaccine NewsStocks moved higher today to start the third quarter after the positive coronavirus vaccine news from Pfizer by skleb1234
Source: Forbes - 🏆 394. / 53 Read more »
Covid-19 vaccine from Pfizer and BioNTech shows 'encouraging' data in early studyA Covid-19 vaccine candidate has yielded positive data in early tests, according to findings released by US drugmaker Pfizer and Germany's BioNTech. Follow live updates: the first PLUMS are every time full of WORMS ! sorry about this . he Covid-19 is a special Virus ! and he isn't a easy one ! Obviously this vaccine is just to inject mind control devices so our ultra important daily tasks can be govt monitored. The near eradication of measles, mumps & polio was because of the much more effective ‘thoughts & prayers’. so they elicited a fever in test subjects - OOOOHHHHH - i'm so excited - sign me up
Source: cnnbrk - 🏆 393. / 55 Read more »